# Shashi Kori

> Shashi Kori is a neurologist and neuro-oncologist turned biotech founder, and the co-founder and CEO of Novilla Pharmaceuticals, a Cambridge-based company using a proprietary AI model to design transdermal formulations that deliver drugs to the site of action while minimizing systemic effects. Before Novilla, he spent decades building pain programs at Duke and the University of South Florida and led clinical development at GlaxoSmithKline, Allergan, MAP Pharmaceuticals and Autonomic Technologies. He partnered with Dr. Eric Fossel in 2019 to merge their drug-delivery innovations into Novilla's pipeline, led by lead candidate NOV-1776.

- **Role:** Co-Founder and CEO at Novilla Pharmaceuticals
- **Organizations:** Novilla Pharmaceuticals, Autonomic Technologies, Allergan, MAP Pharmaceuticals, GlaxoSmithKline, Duke University, University of South Florida College of Medicine, Case Western Reserve University, Memorial Sloan-Kettering Cancer Center
- **From:** India
- **Nationality:** Indian-American
- **Education:** MD (Medical degree), Kasturba Medical College, Mangalore, India, Residency, Internal Medicine, VA Medical Center, Brooklyn, NY, Residency, Neurology, St. Vincent's Hospital and Medical Center, New York, NY, Fellowships in Neuro-oncology, Neuroimmunology & Immunobiology, and Cancer Pain, Memorial Sloan-Kettering Cancer Center, NY
- **Known for:** Co-founded Novilla Pharmaceuticals and serves as CEO, Governor-appointed Pain Commissioner of Florida, Founded, built and ran four large pain programs, including the Pain and Palliative Care Program at Duke University

## Career timeline

- **—** — Founding Director, Pain and Palliative Care Program, Duke University
- **—** — Founder and Vice Chairman, Department of Neurology, University of South Florida College of Medicine
- **—** — Senior Director of Clinical Development and Senior Medical Advisor, Pain/Migraine Team, GlaxoSmithKline
- **—** — Vice President of Clinical Development and Medical Affairs, Allergan and MAP Pharmaceuticals
- **2014** — Appointed Chief Medical Officer, Autonomic Technologies, Inc.
- **2019** — Co-founded Novilla Pharmaceuticals with Dr. Eric Fossel
- **2021** — Novilla raised a Series A round (last raised Nov 2021)

## Achievements

- Co-founded Novilla Pharmaceuticals and serves as CEO
- Governor-appointed Pain Commissioner of Florida
- Founded, built and ran four large pain programs, including the Pain and Palliative Care Program at Duke University
- More than 90 published works (cited as 110+ on Novilla's site)
- 150+ U.S. and international invited lectures on pain and headache management
- Helped develop a large share of the pain and migraine medications in use today
- Editorial board service for medical journals
- Lead candidate NOV-1776 showed significant efficacy in clinical trials, outperforming standard treatments

## Latest updates

- **2021-11** — Novilla Pharmaceuticals raised a Series A round (last raised November 2021).
- **2025-06** — Novilla Pharmaceuticals listed as an exhibitor at the BIO International Convention 2025.

## Links

- Website: https://novilla.com
- LinkedIn: http://www.linkedin.com/in/shashi-kori-33a0a38

---

Profile page: https://yespress.io/shashi-kori
Published by YesPress — https://yespress.io
Last updated: 2026-06-05